PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2025 Earnings Call Transcript May 6, 2025
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $10.04, expectations were $-1.08.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the PTC Therapeutics First Quarter 2025 Earnings Conference Call. [Operator Instructions] Today’s conference is being recorded. I would now like to turn the conference over to Ellen Cavaleri, Head of Investor Relations. Please go...
